Mebhydrolin
Mebhydrolin
|
Systematic (IUPAC) name |
---|
5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
Clinical data |
---|
AHFS/Drugs.com |
International Drug Names |
---|
|
|
---|
|
oral[1] |
---|
Identifiers |
---|
|
524-81-2 N 6153-33-9[2] |
---|
|
R06AX15 |
---|
PubChem |
CID 22530 |
---|
ChemSpider |
21129 Y |
---|
UNII |
9SUK9B7XVY Y |
---|
KEGG |
D08161 Y |
---|
Synonyms |
9-Benzyl-2-methyl-2,3,4,9-tetrahydro-1H-gamma-carboline, Incidal, Omeril, diazolin, Fabahistin, mebhydrolin napadisylate, mebhydroline 1,5-naphthalenedisulfonate[3] |
---|
Chemical data |
---|
Formula |
C19H20N2[4] |
---|
|
276.376 g/mol |
---|
SMILES
- CN3Cc4c1ccccc1n(Cc2ccccc2)c4CC3
|
InChI=1S/C19H20N2/c1-20-12-11-19-17(14-20)16-9-5-6-10-18(16)21(19)13-15-7-3-2-4-8-15/h2-10H,11-14H2,1H3
Y
Key:FQQIIPAOSKSOJM-UHFFFAOYSA-N
Y
|
N (what is this?) (verify) |
---|
Mebhydrolin (INN) or mebhydroline is an antihistamine. It is not available in the United States, but it is in various other countries. It is also called Bexidal (BD) and Diazolin (RU). It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis.
Mebhydrolin has been shown to enhance the performance-deficit effects of alcohol.[5]
References
- ↑ 1.0 1.1 "FABAHISTIN 50 mg (Tablets)". South African Electronic Package Inserts. September 1970. Retrieved 2007-03-02.
- ↑ "Diazoline". National Library of Medicine - Medical Subject Headings. US National Institutes of Health, National Library of Medicine. Retrieved 2007-03-02.
- ↑ "Mebhydroline". National Library of Medicine - Medical Subject Headings. US National Institutes of Health, National Library of Medicine. Retrieved 2007-03-02.
- ↑ "Mebhydrolin chemical information". PubChem. Retrieved 2007-03-02.
- ↑ Franks HM, Lawrie M, Schabinsky VV, Starmer GA, Teo RK (October 1981). "Interaction between ethanol and antihistamines: 3. mebhydrolin". Med. J. Aust. 2 (9): 477–9. PMID 6119605.
|
---|
| Aminoalkyl ethers | |
---|
| Substituted alkylamines | |
---|
| Substituted ethylenediamines | |
---|
| Phenothiazine derivatives | |
---|
| Piperazine derivatives | |
---|
| Others for systemic use | |
---|
| For topical use | |
---|
| |
---|
| Description |
- Physiology
- cells
- autoantigens
- autoantibodies
- complement
- surface antigens
- IG receptors
|
---|
| Disease |
- Allergies
- Immunodeficiency
- Immunoproliferative immunoglobulin disorders
- Hypersensitivity and autoimmune disorders
- Neoplasms and cancer
|
---|
| Treatment |
- Procedures
- Drugs
- antihistamines
- immunostimulants
- immunosuppressants
- monoclonal antibodies
|
---|
|
|
|
---|
| Receptor (ligands) | H1 |
- Non-generational: Atypical antipsychotics (e.g., aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone, zotepine)
- Tetracyclic antidepressants (e.g., amoxapine, loxapine, maprotiline, mianserin, mirtazapine, oxaprotiline)
- Tricyclic antidepressants (e.g., amitriptyline, butriptyline, clomipramine, desipramine, dosulepin (dothiepin), doxepin, imipramine, iprindole, lofepramine, nortriptyline, protriptyline, trimipramine)
- Typical antipsychotics (e.g., chlorpromazine, flupenthixol, fluphenazine, loxapine, perphenazine, prochlorperazine, thioridazine, thiothixene)
- Unknown/unsorted: Belarizine
- Elbanizine
- Flotrenizine
- Napactadine
- Tagorizine
- Trelnarizine
- Trenizine
|
---|
| H2 | |
---|
| H3 | |
---|
| H4 | |
---|
|
---|
| Transporter (inhibitors) | |
---|
| Enzyme (inhibitors) | |
---|
| Others | |
---|
| |
---|
| Description |
- Anatomy
- Physiology
- Development
|
---|
| Disease |
- Congenital
- Neoplasms and cancer
- Chest trauma
- Infection
- common cold
- pneumonia
- tuberculosis
- Other
- Symptoms and signs
|
---|
| Treatment |
- Procedures
- Drugs
- nasal
- throat
- obstructive airway diseases
- cough and cold
- histaminergics
- pulmonary arterial hypertension
- other
- Surgery
|
---|
|
|